Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 1, 2008, Pages 33-41

  Sherif, Ali M ^a   Yoshida, Hiraku ^a   Maruyama, Yukio ^a   Yamamoto, Hiroyasu ^a   Yokoyama, Keitaro ^a   Hosoya, Tatsuo ^a   Kawakami, Makio ^b   Nakayama, Masaaki ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; Peritoneal dialysis; Peritoneal membrane

Indexed keywords

FIBRIN;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCLEROSIS;

ADULT; AGED; BIOPSY; EPITHELIUM; FEMALE; FIBRIN; FIBROSIS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; SCLEROSIS; TIME FACTORS;

EID: 38849173035     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00538.x     Document Type: Article

References (26)

1. Honda K, Nitta K, Horita S et al. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003 19 : 169 75.
2. Kawanishi H, Harada Y, Noriyuki T et al. Treatment options for encapsulating peritoneal sclerosis based on progressive stage. Adv Perit Dial 2001 17 : 200 4.
3. Nakayama M. The plasma leak-to-response hypothesis: a working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment. Perit Dial Int 2005 25 : S71 6.
4. Miyazaki M, Yuzawa Y. The role of peritoneal fibrosis in encapsulating peritoneal sclerosis. Perit Dial Int 2005 25 : S48 56.
5. Nakamoto H. Encapsulating peritoneal sclerosis - a clinician's approach to diagnosis and medical treatment. Perit Dial Int 2005 25 : S30 8.
6. Sherif AM, Nakayama M, Maruyama Y et al. Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients. Nephrol Dial Transplant 2006 21 : 1675 81.
7. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Association between an increased surface area of peritoneal micro vessels and a high peritoneal solute transport rate. Perit Dial Int 2003 23 : 116 22.
8. Honda K, Nitta K, Horita S et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999 14 : 1541 9.
9. Yamamoto R, Otsuka Y, Nakayama M et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol 2005 9 : 148 52.
10. Garosi G, Di Paolo N. Morphological aspects of peritoneal sclerosis. J Nephrol Dec 2001 14 : S30 8.
11. Williams JD, Craig KJ, Topley N et al. Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002 13 : 470 9.
12. Hoff CM. Experimental animal models of encapsulating peritoneal sclerosis. Perit Dial Int 2005 25 : S57 66.
13. Nakamoto H, Imai H, Ishida Y et al. New animal models for encapsulating peritoneal sclerosis, role of acidic solution. Perit Dial Int 2001 21 : S349 453.
14. Suga H, Teraoka S, Ota K et al. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp Toxicol Pathol 1995 47 : 287 91.
15. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000 20 : S43 55.
16. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005 25 : S19 29.
17. Margetts PJ, Gyorffy S, Kolb M et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002 13 : 721 8.
18. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996 28 : 420 7.
19. Nakamoto H, Kawaguchi Y, Suzuki H. Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv Perit Dial 2002 18 : 119 23.
20. Kawanishi H. Surgical treatment for encapsulating peritoneal sclerosis. Adv Perit Dial 2002 18 : 139 43.
21. Novello AC, Port FK. Sclerosing encapsulating peritonitis. Int J Artif Organs 1986 9 : 393 6.
22. Campbell S, Clarke P, Hawley C et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features. Am J Kidney Dis 1994 24 : 819 25.
23. Klimopoulos S, Katsoulis IE, Margellos V, Nikolopoulou N. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis. J R Coll Surg Edinb 2002 47 : 485 90.
24. Perez-Fontan FJ, Soler R, Sanchez J et al. Retractile mesenteritis involving the colon: barium enema, sonographic, and CT findings. AJR Am J Roentgenol 1986 147 : 937 40.
25. Krestin GP, Kacl G, Hoffmann R, Keusch G, Burger HR. The imaging diagnosis of sclerosing peritonitis (SP) following continuous ambulatory peritoneal dialysis (CAPD). Rofo 1992 157 : 506 11.
26. Kowalewska J, Lichodziejewska-Niemierko M, Liberek T et al. Encapsulating peritoneal sclerosis a serious complication of peritoneal dialysis with uncharacteristic symptoms. Wiad Lek 2006 59 : 419 21.